{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:47:32Z","timestamp":1777294052054,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"DOI":"10.7759\/cureus.88234","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T13:26:54Z","timestamp":1752845214000},"source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary Hypertension Among Individuals Living With Hemoglobinopathies: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Collins C","family":"Okeke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Ojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine O","family":"Okere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onyinye E","family":"Ebiliekwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifunanya R","family":"Ekeocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris N","family":"Idion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onyeka","family":"Egemonye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omosimisola O","family":"Alli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euodia A","family":"Ugo-Ihanetu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvahelen","family":"Okorienta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afamefuna O","family":"Onyeogulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elo","family":"Agidah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarachi","family":"Nduji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel I","family":"Akinteye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaoluwa E","family":"Ebiekuraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph O","family":"Egbunike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.988089","article-title":"Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked","volume":"123","author":"Farmakis D","year":"2011","unstructured":"Farmakis D, Aessopos A. Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked. Circulation. 2011, 123:1227-32. 10.1161\/CIRCULATIONAHA.110.988089","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13885","article-title":"The hemoglobinopathies, molecular disease mechanisms and diagnostics","volume":"44 Suppl 1","author":"Harteveld CL","year":"2022","unstructured":"Harteveld CL, Achour A, Arkesteijn SJ, et al.. The hemoglobinopathies, molecular disease mechanisms and diagnostics. Int J Lab Hematol. 2022, 44 Suppl 1:28-36. 10.1111\/ijlh.13885","journal-title":"Int J Lab Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2223\/JPED.1802","article-title":"The genetics of blood disorders: hereditary hemoglobinopathies","volume":"84","author":"Sonati Mde F","year":"2008","unstructured":"Sonati Mde F, Costa FF. The genetics of blood disorders: hereditary hemoglobinopathies. J Pediatr (Rio J). 2008, 84:S40-51. 10.2223\/JPED.1802","journal-title":"J Pediatr (Rio J)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0532","article-title":"Hemoglobinopathies: clinical manifestations, diagnosis, and treatment","volume":"108","author":"Kohne E","year":"2011","unstructured":"Kohne E. Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Dtsch Arztebl Int. 2011, 108:532-40. 10.3238\/arztebl.2011.0532","journal-title":"Dtsch Arztebl Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21035","article-title":"Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease","volume":"83","author":"Taylor JG 6th","year":"2008","unstructured":"Taylor JG 6th, Ackah D, Cobb C, et al.. Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease. Am J Hematol. 2008, 83:6-14. 10.1002\/ajh.21035","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.18811.1","article-title":"The 6th World Symposium on Pulmonary Hypertension: what's old is new","volume":"8","author":"Condon DF","year":"2019","unstructured":"Condon DF, Nickel NP, Anderson R, Mirza S, de Jesus Perez VA. The 6th World Symposium on Pulmonary Hypertension: what's old is new. F1000Res. 2019, 8:F1000 Faculty Rev-888. 10.12688\/f1000research.18811.1","journal-title":"F1000Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.720643","article-title":"Importance of tricuspid regurgitation velocity threshold in risk assessment of pulmonary hypertension-long-term outcome of patients submitted to aortic valve replacement","volume":"8","author":"Garcia-Ribas C","year":"2021","unstructured":"Garcia-Ribas C, Ble M, G\u00f3mez M, Mas-Stachurska A, Farr\u00e9-L\u00f3pez N, Cladellas M. Importance of tricuspid regurgitation velocity threshold in risk assessment of pulmonary hypertension-long-term outcome of patients submitted to aortic valve replacement. Front Cardiovasc Med. 2021, 8:720643. 10.3389\/fcvm.2021.720643","journal-title":"Front Cardiovasc Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcchd.2025.100586","article-title":"Pulmonary hypertension aetiologies in different parts of the world","volume":"20","author":"Butrous G","year":"2025","unstructured":"Butrous G. Pulmonary hypertension aetiologies in different parts of the world. Int J Cardiol Congenit Heart Dis. 2025, 20:100586. 10.1016\/j.ijcchd.2025.100586","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2471\/blt.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell B","year":"2008","unstructured":"Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008, 86:480-7. 10.2471\/blt.06.036673","journal-title":"Bull World Health Organ"},{"key":"ref10","article-title":"Pulmonary hypertension associated with hemolytic anemia","volume":"8","author":"Sun N","year":"2024","unstructured":"Sun N. Pulmonary hypertension associated with hemolytic anemia. J Coronary Heart Dis. 2024, 8:1-2.","journal-title":"J Coronary Heart Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Rayyan. Overview. (2025). Accessed. February 11, 2025: https:\/\/new.rayyan.ai\/reviews\/1316152\/overview.","DOI":"10.5339\/jist.2025.15"},{"key":"ref13","unstructured":"JBI Critical Appraisal Tools. (2024). Accessed. October 26, 2024: https:\/\/jbi.global\/critical-appraisal-tools."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-074849","article-title":"Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease","volume":"111","author":"Ashley-Koch AE","year":"2008","unstructured":"Ashley-Koch AE, Elliott L, Kail ME, et al.. Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood. 2008, 111:5721-6. 10.1182\/blood-2007-02-074849","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1179\/1607845415Y.0000000014","article-title":"Pulmonary hypertension in non-transfusion-dependent thalassemia: correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron","volume":"20","author":"Inthawong K","year":"2015","unstructured":"Inthawong K, Charoenkwan P, Silvilairat S, et al.. Pulmonary hypertension in non-transfusion-dependent thalassemia: correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron. Hematology. 2015, 20:610-7. 10.1179\/1607845415Y.0000000014","journal-title":"Hematology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2011.05.013","article-title":"Risk factors for pulmonary hypertension in patients with \u03b2 thalassemia intermedia","volume":"22","author":"Karimi M","year":"2011","unstructured":"Karimi M, Musallam KM, Cappellini MD, et al.. Risk factors for pulmonary hypertension in patients with \u03b2 thalassemia intermedia. Eur J Intern Med. 2011, 22:607-10. 10.1016\/j.ejim.2011.05.013","journal-title":"Eur J Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0948","article-title":"Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival","volume":"101","author":"Castro O","year":"2003","unstructured":"Castro O, Hoque M, Brown BD. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood. 2003, 101:1257-61. 10.1182\/blood-2002-03-0948","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12242","article-title":"Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E\/\u03b2-thalassemia disease","volume":"92","author":"Atichartakarn V","year":"2014","unstructured":"Atichartakarn V, Chuncharunee S, Archararit N, Udomsubpayakul U, Lee R, Tunhasiriwet A, Aryurachai K. Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E\/\u03b2-thalassemia disease. Eur J Haematol. 2014, 92:346-53. 10.1111\/ejh.12242","journal-title":"Eur J Haematol"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.4103\/ajoim.ajoim_23_21","article-title":"Pulmonary hypertension in people with sickle cell disease in a Nigerian tertiary hospital","volume":"12","author":"Odeyemi AO","year":"2022","unstructured":"Odeyemi AO, Oni OO, Odeyemi AO, et al.. Pulmonary hypertension in people with sickle cell disease in a Nigerian tertiary hospital. Assam J Intern Med. 2022, 12:3-9.","journal-title":"Assam J Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137539","article-title":"Risk factors of pulmonary hypertension in Brazilian patients with sickle cell anemia","volume":"10","author":"Lobo CL","year":"2015","unstructured":"Lobo CL, do Nascimento EM, Abelha R, Queiroz AM, Connes P, Cardoso GP, Ballas SK. Risk factors of pulmonary hypertension in Brazilian patients with sickle cell anemia. PLoS one. 2015, 10:e0137539. 10.1371\/journal.pone.0137539","journal-title":"PLoS one"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.002124","article-title":"Prevalence and risk factors for pulmonary arterial hypertension in a large group of \u03b2-thalassemia patients using right heart catheterization: a Webthal study","volume":"129","author":"Derchi G","year":"2014","unstructured":"Derchi G, Galanello R, Bina P, et al.. Prevalence and risk factors for pulmonary arterial hypertension in a large group of \u03b2-thalassemia patients using right heart catheterization: a Webthal study. Circulation. 2014, 129:338-45. 10.1161\/CIRCULATIONAHA.113.002124","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/trz038","article-title":"Pulmonary hypertension and right ventricular function in Nigerian children with sickle cell anaemia","volume":"113","author":"Peter ID","year":"2019","unstructured":"Peter ID, Asani MO, Abdullahi SU, Aliyu I, Obaro SK, Bode-Thomas F. Pulmonary hypertension and right ventricular function in Nigerian children with sickle cell anaemia. Trans R Soc Trop Med Hyg. 2019, 113:489-96. 10.1093\/trstmh\/trz038","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12261","article-title":"Effect of genotype on pulmonary hypertension risk in patients with thalassemia","volume":"92","author":"Teawtrakul N","year":"2014","unstructured":"Teawtrakul N, Ungprasert P, Pussadhamma B, et al.. Effect of genotype on pulmonary hypertension risk in patients with thalassemia. Eur J Haematol. 2014, 92:429-34. 10.1111\/ejh.12261","journal-title":"Eur J Haematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21058","article-title":"Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes","volume":"83","author":"De Castro LM","year":"2008","unstructured":"De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol. 2008, 83:19-25. 10.1002\/ajh.21058","journal-title":"Am J Hematol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21016","article-title":"Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency","volume":"83","author":"Gordeuk VR","year":"2008","unstructured":"Gordeuk VR, Sachdev V, Taylor JG, Gladwin MT, Kato G, Castro OL. Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol. 2008, 83:15-8. 10.1002\/ajh.21016","journal-title":"Am J Hematol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4102\/ajlm.v12i1.2225","article-title":"Bridging the gaps in newborn screening programmes: challenges and opportunities to detect haemoglobinopathies in Africa","volume":"12","author":"Twum S","year":"2023","unstructured":"Twum S, Fosu K, Felder RA, Sarpong KA. Bridging the gaps in newborn screening programmes: challenges and opportunities to detect haemoglobinopathies in Africa. Afr J Lab Med. 2023, 12:2225. 10.4102\/ajlm.v12i1.2225","journal-title":"Afr J Lab Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biodatasci-102920-112550","article-title":"African global representation in biomedical sciences","volume":"4","author":"Mulder N","year":"2021","unstructured":"Mulder N, Zass L, Hamdi Y, Othman H, Panji S, Allali I, Fakim YJ. African global representation in biomedical sciences. Annu Rev Biomed Data Sci. 2021, 4:57-81. 10.1146\/annurev-biodatasci-102920-112550","journal-title":"Annu Rev Biomed Data Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099489","article-title":"Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom","volume":"9","author":"Gladwin MT","year":"2014","unstructured":"Gladwin MT, Barst RJ, Gibbs JS, et al.. Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. PLoS One. 2014, 9:e99489. 10.1371\/journal.pone.0099489","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06110.x","article-title":"Pulmonary hypertension in patients with sickle cell disease: a longitudinal study","volume":"134","author":"Ataga KI","year":"2006","unstructured":"Ataga KI, Moore CG, Jones S, Olajide O, Strayhorn D, Hinderliter A, Orringer EP. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol. 2006, 134:109-15. 10.1111\/j.1365-2141.2006.06110.x","journal-title":"Br J Haematol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-023-01678-7","article-title":"The prevalence of pulmonary arterial hypertension in patients with beta thalassemia major","volume":"40","author":"Kahnoji M","year":"2024","unstructured":"Kahnoji M, Bitaraf S, Soltani N, Esmaeili-Nadimi H. The prevalence of pulmonary arterial hypertension in patients with beta thalassemia major. Indian J Hematol Blood Transfus. 2024, 40:74-7. 10.1007\/s12288-023-01678-7","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.128059","article-title":"Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases","volume":"33","author":"Haque AK","year":"2002","unstructured":"Haque AK, Gokhale S, Rampy BA, Adegboyega P, Duarte A, Saldana MJ. Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Hum Pathol. 2002, 33:1037-43. 10.1053\/hupa.2002.128059","journal-title":"Hum Pathol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201408-405CME","article-title":"Pulmonary hypertension in sickle cell disease","volume":"11","author":"Hayes MM","year":"2014","unstructured":"Hayes MM, Vedamurthy A, George G, et al.. Pulmonary hypertension in sickle cell disease. Ann Am Thorac Soc. 2014, 11:1488-9. 10.1513\/AnnalsATS.201408-405CME","journal-title":"Ann Am Thorac Soc"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato GJ","year":"2006","unstructured":"Kato GJ, McGowan V, Machado RF, et al.. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006, 107:2279-85. 10.1182\/blood-2005-06-2373","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin MT","year":"2004","unstructured":"Gladwin MT, Sachdev V, Jison ML, et al.. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004, 350:886-95. 10.1056\/NEJMoa035477","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141706","article-title":"Hydroxyurea-increased fetal hemoglobin is associated with less organ damage and longer survival in adults with sickle cell anemia","volume":"10","author":"Fitzhugh CD","year":"2015","unstructured":"Fitzhugh CD, Hsieh MM, Allen D, et al.. Hydroxyurea-increased fetal hemoglobin is associated with less organ damage and longer survival in adults with sickle cell anemia. PLoS One. 2015, 10:e0141706. 10.1371\/journal.pone.0141706","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1177\/10742484211006531","article-title":"Combination therapy in pulmonary arterial hypertension-targeting the nitric oxide and prostacyclin pathways","volume":"26","author":"Mandras S","year":"2021","unstructured":"Mandras S, Kovacs G, Olschewski H, Broderick M, Nelsen A, Shen E, Champion H. Combination therapy in pulmonary arterial hypertension-targeting the nitric oxide and prostacyclin pathways. J Cardiovasc Pharmacol Ther. 2021, 26:453-62. 10.1177\/10742484211006531","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200868030-00009","article-title":"Sildenafil: a review of its use in pulmonary arterial hypertension","volume":"68","author":"Croom KF","year":"2008","unstructured":"Croom KF, Curran MP. Sildenafil: a review of its use in pulmonary arterial hypertension. Drugs. 2008, 68:383-97. 10.2165\/00003495-200868030-00009","journal-title":"Drugs"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05432.x","article-title":"Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension","volume":"129","author":"Machado RF","year":"2005","unstructured":"Machado RF, Gladwin MT. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol. 2005, 129:449-64. 10.1111\/j.1365-2141.2005.05432.x","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/384502-pulmonary-hypertension-among-individuals-living-with-hemoglobinopathies-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T13:26:56Z","timestamp":1752845216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/384502-pulmonary-hypertension-among-individuals-living-with-hemoglobinopathies-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.88234","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,18]]}}}